Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997753349> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2997753349 endingPage "15" @default.
- W2997753349 startingPage "10" @default.
- W2997753349 abstract "Spinal cord injury (SCI) can lead to detrusor overactivity and detrusor-sphincter dyssynergia, which result in inefficient voiding and bladder wall tissue remodeling such as hypertrophy and fibrosis. However, no effective modality for controlling the bladder remodeling is available. In order to clarify whether an alpha1A/D-adrenoceptor (α1A/D-AR) antagonist, naftopidil, or a phosphodiesterase type 5 (PDE-5) inhibitor, tadalafil, prevents bladder wall remodeling after SCI, we examined the bladder and urethral activity as well as ischemic and fibrotic changes in the bladder using SCI rats with or without naftopidil or tadalafil treatment. Adult female Sprague-Dawley rats were divided into 4 groups; (1) normal (spinal cord intact), (2) vehicle SCI, (3) naftopidil SCI, and (4) tadalafil SCI groups. In SCI groups, rats underwent Th9-10 spinal cord transection followed by oral application of vehicle, naftopidil or tadalafil for 12 weeks. Bladder and urethral pressures, mRNA levels of fibrosis-related molecules and ischemia markers and the composition of bladder collagen and elastin were evaluated. Naftopidil treatment reduced the upregulation of mRNA levels of ischemia and fibrosis markers at the early phase of SCI, and ameliorated the decrease of bladder compliance and voiding efficiency, and the increase of collagen concentration in the bladder wall at the late phase of SCI. Tadalafil treatment reduced the upregulation of mRNA levels of fibrosis markers, the decrease of bladder compliance and the increase of collagen concentration at the late phase of SCI. These results suggest that PDE-5 inhibitors and α1A/D-AR antagonists treatments improved the bladder remodeling after SCI." @default.
- W2997753349 created "2020-01-10" @default.
- W2997753349 creator A5045164790 @default.
- W2997753349 creator A5087088713 @default.
- W2997753349 creator A5089621431 @default.
- W2997753349 date "2020-01-01" @default.
- W2997753349 modified "2023-09-25" @default.
- W2997753349 title "Effects of alpha-1A/D adrenoceptor antagonist and phosphodiesterase type 5 inhibitor on bladder remodeling in rats with spinal cord injury" @default.
- W2997753349 cites W1580343424 @default.
- W2997753349 cites W1999406153 @default.
- W2997753349 cites W2005781356 @default.
- W2997753349 cites W2008946188 @default.
- W2997753349 cites W2045995346 @default.
- W2997753349 cites W2050746631 @default.
- W2997753349 cites W2051838969 @default.
- W2997753349 cites W2056047130 @default.
- W2997753349 cites W2059601601 @default.
- W2997753349 cites W2070755486 @default.
- W2997753349 cites W2071686042 @default.
- W2997753349 cites W2074435320 @default.
- W2997753349 cites W2086063691 @default.
- W2997753349 cites W2087111859 @default.
- W2997753349 cites W2139049527 @default.
- W2997753349 cites W1494508678 @default.
- W2997753349 doi "https://doi.org/10.1254/fpj.19108" @default.
- W2997753349 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31902838" @default.
- W2997753349 hasPublicationYear "2020" @default.
- W2997753349 type Work @default.
- W2997753349 sameAs 2997753349 @default.
- W2997753349 citedByCount "0" @default.
- W2997753349 crossrefType "journal-article" @default.
- W2997753349 hasAuthorship W2997753349A5045164790 @default.
- W2997753349 hasAuthorship W2997753349A5087088713 @default.
- W2997753349 hasAuthorship W2997753349A5089621431 @default.
- W2997753349 hasBestOaLocation W29977533491 @default.
- W2997753349 hasConcept C118552586 @default.
- W2997753349 hasConcept C126322002 @default.
- W2997753349 hasConcept C126894567 @default.
- W2997753349 hasConcept C134018914 @default.
- W2997753349 hasConcept C2776768464 @default.
- W2997753349 hasConcept C2778334475 @default.
- W2997753349 hasConcept C2780559512 @default.
- W2997753349 hasConcept C2780775167 @default.
- W2997753349 hasConcept C2780816001 @default.
- W2997753349 hasConcept C2781045395 @default.
- W2997753349 hasConcept C71924100 @default.
- W2997753349 hasConcept C74534348 @default.
- W2997753349 hasConcept C77411442 @default.
- W2997753349 hasConceptScore W2997753349C118552586 @default.
- W2997753349 hasConceptScore W2997753349C126322002 @default.
- W2997753349 hasConceptScore W2997753349C126894567 @default.
- W2997753349 hasConceptScore W2997753349C134018914 @default.
- W2997753349 hasConceptScore W2997753349C2776768464 @default.
- W2997753349 hasConceptScore W2997753349C2778334475 @default.
- W2997753349 hasConceptScore W2997753349C2780559512 @default.
- W2997753349 hasConceptScore W2997753349C2780775167 @default.
- W2997753349 hasConceptScore W2997753349C2780816001 @default.
- W2997753349 hasConceptScore W2997753349C2781045395 @default.
- W2997753349 hasConceptScore W2997753349C71924100 @default.
- W2997753349 hasConceptScore W2997753349C74534348 @default.
- W2997753349 hasConceptScore W2997753349C77411442 @default.
- W2997753349 hasIssue "1" @default.
- W2997753349 hasLocation W29977533491 @default.
- W2997753349 hasLocation W29977533492 @default.
- W2997753349 hasOpenAccess W2997753349 @default.
- W2997753349 hasPrimaryLocation W29977533491 @default.
- W2997753349 hasRelatedWork W1559582992 @default.
- W2997753349 hasRelatedWork W2046101516 @default.
- W2997753349 hasRelatedWork W2050390062 @default.
- W2997753349 hasRelatedWork W2081375755 @default.
- W2997753349 hasRelatedWork W2529363292 @default.
- W2997753349 hasRelatedWork W2748812437 @default.
- W2997753349 hasRelatedWork W2800452484 @default.
- W2997753349 hasRelatedWork W2997753349 @default.
- W2997753349 hasRelatedWork W3209401362 @default.
- W2997753349 hasRelatedWork W2017995614 @default.
- W2997753349 hasVolume "155" @default.
- W2997753349 isParatext "false" @default.
- W2997753349 isRetracted "false" @default.
- W2997753349 magId "2997753349" @default.
- W2997753349 workType "article" @default.